ANSWERS/GUARANTEED SUCCESS
1.what does coronary artery disease consist of? (pharm pg. 330): narrowing or
obstruction of the arteries of the heart
2.what does coronary artery disease lead to? (3)
(pharm pg. 330): angina pectoris
myocardial
infarction stroke
3.what is the main cause of diseases that reduce the quality of life and end lives
prematurely?(pharm pg. 330): lifestyle
4.what is metabolic syndrome? (pharm pg. 330): insulin resistance syndrome
5.what are the 5 key characteristics of metabolic syndrome? (pharm pg. 331):
type 2 diabetes
abdominal obesity
hypertriglyceridemi
/ 21
,a low levels of HDLs
hypertension
6.what are the 2 risk factors for the development of metabolic syndrome? (pharm
pg. 331): obesity
sedentary lifestyle
7.What are 3 negative lifestyle choices that aggravate metabolic syndrome? (pharm
pg. 332): excessive amounts of alcohol consumption
cigarette smoking
stress
8.what diets help treat metabolic syndrome? (pharm pg. 332): DASH diet
mediterranean diet
9.What does DASH stand for? (pharm pg. 332): Dietary Approaches to Stop
Hypertension
10.what are 4 nonpharmacologic therapies that can be used to treat metabolic
syndrome? (pharm pg. 332): eliminating cigarette smoking
restricting alcohol consumption
reducing stress
/ 21
, controlling sodium intake
11.where is the primary prevention of metabolic syndrome coming from? (pharm
pg. 334): grade school curriculum
12.what does this curriculum focus on? (pharm pg. 334): the importance of
moderate activity, dietary choices, and the prevention of alcohol
consumption and smoking
13.what is a main resource the grade school uses to prevent metabolic
syndrome? (pharm pg. 335): MyPlate
14.what is MyPlate used for? (pharm pg. 335): as a guideline for age and
gender related activity and dietary information
15.what are the ranges for stage 1 hypertension (systolic)? (pharm pg. 355)-
: 130-139
16.what are the ranges for stage 1 hypertension (diastolic)? (pharm pg. 355)-
: 80 to 89
17.if a patient is diagnosed with hypertension stage 1 is there a need for lifestyle
modification? (pharm pg. 335): yes
/ 21